Highlights and Quick Summary
- Annual 10Y Shareholders Equity Growth (per Share) for 2022 was -35.4% (a 42.63% increase from previous year)
- Annual 10Y Shareholders Equity Growth (per Share) for 2021 was -24.82% (a -Infinity% decrease from previous year)
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 10Y Shareholders Equity Growth (per Share) of BRIACELL THERAP
Most recent 10Y Shareholders Equity Growth (per Share)of BCTX including historical data for past 10 years.Interactive Chart of 10Y Shareholders Equity Growth (per Share) of BRIACELL THERAP
BRIACELL THERAP 10Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | – | – | – | -35.4% |
2021 | – | – | – | – | -24.82% |
2020 | – | – | – | – | 0.0% |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology